The study by Demirović et al. [59] investigated the expression of MAGE-A3/4 and NY-ESO-1 in RO and ChRCC, finding significant differences in the expression of these cancer testis antigens between the two tumour types, which may have diagnostic implications. The gene discussed is CTAG1B; the disease is chromophobe renal cell carcinoma.